Michael Grey is the co-founder and current Chair of the Board at Mirum Pharmaceuticals, a company focused on developing treatments for liver diseases. Born in 1973, he has a long history in the pharmaceutical industry, bringing over 45 years of...

Michael Grey is the co-founder and current Chair of the Board at Mirum Pharmaceuticals, a company focused on developing treatments for liver diseases. Born in 1973, he has a long history in the pharmaceutical industry, bringing over 45 years of experience to his role. Michael previously served as CEO and Executive Chairman at Mirum Pharmaceuticals and held executive roles at several other companies including Amplyx Pharmaceuticals and Curzion Pharmaceuticals. Notably, he transitioned to his current leadership position in 2020 after stepping back from day-to-day operations. His background includes significant financial investment and strategic insight, making him a key player in guiding Mirum's mission. Interestingly, his compensation structure shows a pivotal change in 2022 where he reported no salary or bonuses, indicating a focus on long-term company performance over immediate personal gain. This aligns with his commitment to shareholder value rather than short-term rewards, positioning him as a leader prioritizing the company's future.